Subcutaneous Bortezomib, Thalidomide and Dexamethasone As Induction Therapy Prior to Autologous Peripheral Blood Stem Cell Transplantation in Young Patients Diagnosed of Multiple Myeloma. a Retrospective Analysis from Two Centers

Por: De La Torre, DJR, Ibarra, G, Encuentra, M, Abril, L, Oriol, A, Ribera, JM and Sureda, A

---

Publicada: 13 nov 2019

---

---

Filiaciones:
De La Torre, DJR:
 Hosp Duran & Reynals, Inst Catala Oncol Hosp, Dept Clin Hematol, Barcelona, Spain

:
 Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Josep Carreras Leukaemia Res Inst, Badalona, Spain

Encuentra, M:
 Hosp Duran & Reynals, Inst Catala Oncol Hosp, Dept Clin Hematol, Barcelona, Spain

:
 Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Hosp Univ Germans Trias & Pujol, Badalona, Spain

:
 Hosp Badalona Germans Trias & Pujol, Badalona, Spain

:
 Univ Autonoma Barcelona, Josep Carreras Leukemia Res Inst IJC, ICO Badalona, Hosp Germans Trias & Pujol, Badalona, Spain

Sureda, A:
 Hosp Duran & Reynals, Dept Clin Hematol, IDIBELL, Inst Catala Oncol, Barcelona, Spain